🇺🇸 FDA
Patent

US 11642366

Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy

granted A61KA61K31/727A61K31/728

Quick answer

US patent 11642366 (Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy) held by GLYCOMIRA THERAPEUTICS, INC. expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GLYCOMIRA THERAPEUTICS, INC.
Grant date
Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/727, A61K31/728, A61K31/737, A61K45/06